ArticleJournal for immunotherapy of cancer2022

Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer.

Jian Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.